It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Due to the rise in bacterial resistance, the antibacterial extractions from Chinese herbs have been used more frequently for wound care. In this work, baicalin, an extraction from the Chinese herb Scutellaria baicalensis, was utilized as the antibacterial component in the poly(ε-caprolactone)/MXene (PCL/Ti3C2TX) hybrid nanofibrous membranes for wound dressing. The results revealed that the presence of Ti3C2TX aided in the diameter reduction of the electrospun nanofibers. The PCL hybrid membrane containing 3 wt% Ti3C2TX nanoflakes and 5 wt% baicalin exhibited the smallest mean diameter of 210 nm. Meanwhile, the antibacterial tests demonstrated that the PCL ternary hybrid nanofibers containing Ti3C2TX and baicalin exhibited adequate antibacterial activity against the Gram-positive bacterial S. aureus due to the good synergistic effects of Ti3C2TX naoflakes and baicalin. The addition of Ti3C2TX nanoflakes and baicalin could significantly improve the hydrophilicity of the membranes, resulting in the release of baicalin from the nanofibers. In addition, the cytotoxicity of the nanofibers on rat skeletal myoblast L6 cells confirmed their good compatibility with these PCL-based nanofibrous membrances. This work offers a feasible way to prepare antibacterial nanofibrous membranes using Chinese herb extraction for wound dressing applications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 The Second People’s Hospital of Longgang District, Shenzhen, China; Jinan University, Shenzhen Baoan Women’s and Children’s Hospital, Shenzhen, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548)
2 The Chinese University of Hong Kong, Accident and Emergency Medicine Academic Unit, Hong Kong, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482)
3 Jinan University, Shenzhen Baoan Women’s and Children’s Hospital, Shenzhen, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548)
4 Zhejiang Sci-Tech University, College of Life Sciences and Medicine, Hangzhou, China (GRID:grid.413273.0) (ISNI:0000 0001 0574 8737)
5 Affiliated to Kangda College of Nanjing Medical University, Lianshui People’s Hospital, Huaian, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)